By jurisdiction
Canada (Health Canada)
Every compound we track that has a recorded status under Canada (Health Canada). Tap a name for the full picture, including the U.S. status and primary sources.
| Compound | Status here | Note |
|---|---|---|
| Cagrilintide | Under review | Cagrilintide/semaglutide new drug submission (Novo Nordisk) accepted into Health Canada review in March 2026; no cagrilintide product yet authorized in the Drug Product Database. |
| AOD-9604 | Restricted | Not in the Drug Product Database; Health Canada advisories in Aug and Dec 2025 list seized AOD-9604 among unauthorized injectable peptide drugs, which it regulates as prescription drugs. |
| BPC-157 | Restricted | Not an authorized drug; Health Canada’s April 2026 advisory names BPC-157 among unauthorized injectable peptides and states such products are illegal to sell in Canada. |
| CJC-1295 | Restricted | Not authorized by Health Canada; named in an April 2026 public advisory on unauthorized injectable peptides, which states such products are illegal to sell and reports seizures. |
| Dihexa | Restricted | No product in the Drug Product Database, so it has no DIN and cannot lawfully be sold as a drug; no Health Canada advisory names it. |
| Emideltide (DSIP) | Restricted | Not authorized in Canada; Health Canada’s April 2026 advisory names DSIP among unauthorized injectable peptide drugs that are illegal to sell. |
| Epitalon | Restricted | Named in Health Canada’s April 2026 advisory on unauthorized injectable peptides; absent from the Drug Product Database, so sale for human use is illegal under the Food and Drugs Act. |
| GHK-Cu | Restricted | Not in the Drug Product Database; Health Canada recalled GHK-Cu powder as an unauthorized active pharmaceutical ingredient in May 2026. |
| Ipamorelin | Restricted | Not authorized for sale; Health Canada’s April 2026 advisory names ipamorelin as an unauthorized injectable peptide drug that is illegal to sell in Canada. |
| Kisspeptin-10 | Restricted | Not in the Drug Product Database; Health Canada has listed kisspeptin products among unauthorized products seized in Calgary (Apr 2025), from Canada Peptide (Aug 2025) and at Rize Fitness (Dec 2025). |
| KPV | Restricted | Not authorized for sale; listed in an April 2026 Health Canada advisory among unauthorized injectable peptide drugs it has seized, with peptides generally regulated as prescription drugs in Canada. |
| LL-37 (cathelicidin) | Restricted | Not in the Drug Product Database; a Health Canada advisory (Aug 1, 2025) lists seized LL-37 among unauthorized injectable peptide drugs, which it regulates as prescription drugs. |
| Melanotan II | Restricted | Not authorized for sale; Health Canada names Melanotan I and II among unauthorized injectable peptide drugs it has seized, warning that unauthorized drug products are illegal in Canada. |
| MOTS-c | Restricted | Named in Health Canada’s April 2026 advisory on unauthorized injectable peptides; unauthorized drug products are illegal to sell in Canada. |
| NAD+ | Restricted | No approved injectable NAD+ in the Drug Product Database; an April 2026 Health Canada advisory lists NAD+ among unauthorized injectable drugs illegal to sell; oral NAD+ is regulated as a natural health product. |
| PT-141 (bremelanotide) | Restricted | No authorized product in the Drug Product Database; Health Canada named bremelanotide among unauthorized injectable peptide drugs seized from Canada Peptide (advisory updated Aug 1, 2025). |
| Retatrutide | Restricted | Not authorized by Health Canada; named in an April 2026 advisory on unauthorized injectable peptide drugs - unauthorized drug products are illegal to sell in Canada. |
| Selank | Restricted | Not authorized by Health Canada; a 2025 public advisory named Selank among seized unauthorized injectable peptide drugs, stating that selling unauthorized drugs is illegal in Canada. |
| Semaglutide (compounded) | Restricted | Authorized prescription-only medicine (Ozempic, Wegovy), and generic semaglutide has been on sale since May 2026 (Dr. Reddy’s from May 6, Apotex from May 14); both had Type II recalls in Aug-Sep 2026 (an impurity out of specification; a pen showing the wrong dose). Compounded copies of marketed drugs are not permitted outside a shortage, and Health Canada has recalled compounded semaglutide made with an unauthorized API. |
| Semax | Restricted | No Health Canada authorization; named in an August 2025 Health Canada seizure advisory on unauthorized injectable peptides, which cannot legally be sold in Canada. |
| Sermorelin | Restricted | Named on the Prescription Drug List (‘Sermorelin or its salts’, effective 2013-12-19); no product currently authorized in the Drug Product Database. |
| SS-31 (elamipretide) | Restricted | Not in the Drug Product Database; Health Canada’s Apr 9, 2026 advisory names SS-31 among unauthorized injectable peptide drugs it has seized. |
| TB-500 (Thymosin Beta-4) | Restricted | Not authorized for sale; Health Canada has seized TB-500 among unauthorized injectable peptides and states selling unauthorized drugs is illegal in Canada. |
| Tesamorelin | Restricted | On the Prescription Drug List since 2014-04-25 (‘Tesamorelin or its salts or derivatives’); both Egrifta DINs are cancelled (2022, 2023), so no product is currently authorized for sale. Named among seized unauthorized peptides (Aug 2025). |
| Thymosin Alpha-1 | Restricted | Not authorized for sale; no Drug Product Database listing, and Health Canada named thymosin alpha-1 among unauthorized injectable peptides seized in April 2025. |
| Tirzepatide (compounded) | Restricted | Authorized prescription-only medicine (Mounjaro); compounded copies of marketed drugs are not permitted outside a shortage, and Health Canada warns selling unauthorized versions is illegal in Canada. |